Financials

  • Market Capitalization 1.07 B
  • Employee 221
  • Founded 1998
  • CEO Matt Kapusta
  • Website www.uniqure.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.92
Relación precio/flujo de caja
85.48

uniQure N.V

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

Noticias